Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025 and to consider recommending payment of dividend to the shareholders.